SNSE Sensei Biotherapeutics, Inc. - Common Stock
$16,77
Cena · Maj 19, 2026
Dane fundamentalne na dzień Mar 30, 2026
Zakres 52 tyg.
$5–$37
37% of range
Ocena Analityków
STRONG BUY
8 analysts
Cena Docelowa
$50
+198% upside
P/E (TTM)
-0.6
ROE
-91.9%
Marża Zysku Netto
—
SNSE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$16.77
Kapitalizacja Rynkowa
$13M
P/E (TTM)
-0.6
EPS (TTM)
$-16.72
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-91.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$5 – $37
SNSE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-16.72
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-20M
2021-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
SNSE
Mediana porównawcza
P/E (TTM)
-0.6
0.1
P/B
0.7
1.7
Price / FCF (Cena / FCF)
-0.7
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
SNSE
Mediana porównawcza
ROA
-61.8%
-70.0%
ROE
-91.9%
-143.6%
ROIC
-119.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
SNSE
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5.1
3.3
Quick Ratio (Wskaźnik Szybkości)
2.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
SNSE
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
SNSE
Mediana porównawcza
SNSE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 3 37,5%
- Kup 3 37,5%
- Trzymaj 2 25,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-05-14
Niski
$50.00
Wysoki
$50.00
Średni cel
$50.00
+198,2%
Średnia cel
$50.00
+198,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-4.3%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-28.79 | $-0.63 | -28.2% |
| 31 grudnia 2025 | $-3.74 | $-4.91 | 1.2% |
| 30 września 2025 | $-3.62 | $-4.19 | 0.57% |
| 30 czerwca 2025 | $-3.91 | $-5.71 | 1.8% |
| 31 marca 2025 | $-5.40 | $-4.56 | -0.84% |
| 31 grudnia 2024 | $-6.20 | $-5.64 | -0.56% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| SNSE | $13M | -0.6 | — | — | -91.9% | — |
| VTGN | — | -1.5 | -54.3% | -10579.8% | -67.9% | — |
| CLRB | — | -0.4 | — | — | — | — |
| KTTA | — | — | — | — | — | — |
| JSPR | — | -0.5 | — | — | — | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| GRDX | $20M | -1.1 | — | -17634.4% | -68.6% | -1813.6% |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $11M | $13M | $19M | $20M | $16M | $8M | |
| Operating Expenses | $22M | $33M | $37M | $50M | $37M | $19M | |
| Operating Income | $-22M | $-33M | $-37M | $-50M | $-37M | $-19M | |
| Interest Expense | $32.0K | $90.0K | $144.0K | $219.0K | $670.0K | $2M | |
| Other Non-op | $-4.0K | $-3.0K | $-215.0K | $36.0K | $-9.0K | · | |
| Pretax Income | $-21M | $-30M | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-21M | $-30M | $-34M | $-49M | $-37M | $-20M | |
| EPS (Basic) | $-16.72 | $-24.01 | $-1.22 | $-1.58 | $-1.33 | · | |
| EPS (Diluted) | $-16.72 | $-24.01 | $-1.22 | $-1.58 | $-1.33 | · | |
| Shares (Basic) | 1,260,772 | 1,255,776 | 27,952,857 | 30,703,295 | 27,710,686 | · | |
| Shares (Diluted) | 1,260,772 | 1,255,776 | 27,952,857 | 30,703,295 | 27,710,686 | · | |
| EBITDA | $-22M | $-32M | $-36M | · | $-37M | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $10M | $13M | $18M | $7M | $17M | |
| Short-term Investments | · | · | · | · | $140M | · | |
| Prepaid Expense | $231.0K | $474.0K | $1M | $1M | $547.0K | $1M | |
| Other Current Assets | $92.0K | $120.0K | $325.0K | $344.0K | $374.0K | · | |
| Current Assets | $22M | $42M | $67M | $109M | $149M | $20M | |
| PP&E (Net) | $82.0K | $417.0K | $1M | $2M | $5M | $1M | |
| PP&E (Gross) | $622.0K | $2M | $3M | $3M | $6M | $2M | |
| Accum. Depreciation | $540.0K | $1M | $2M | $1M | $1M | $595.0K | |
| Other Non-current Assets | $18.0K | $48.0K | $86.0K | $63.0K | $39.0K | $86.0K | |
| Total Assets | $23M | $45M | $74M | $118M | $153M | $21M | |
| Accounts Payable | $689.0K | $244.0K | $573.0K | $4M | $2M | $4M | |
| Accrued Liabilities | $715.0K | $847.0K | $900.0K | · | · | · | |
| Current Liabilities | $4M | $5M | $6M | $9M | $5M | $5M | |
| Capital Leases | $59.0K | $1M | $3M | $4M | · | · | |
| Other Non-current Liabilities | · | · | $67.0K | $0 | $149.0K | $52.0K | |
| Total Liabilities | $4M | $7M | $9M | $15M | $7M | $6M | |
| Long-term Debt | · | · | · | · | · | $567.0K | |
| Common Stock | $0 | $0 | $3.0K | $3.0K | $3.0K | · | |
| Retained Earnings | $-283M | $-262M | $-232M | $-198M | $-149M | $-112M | |
| AOCI | $1.0K | $-13.0K | $-209.0K | $-1M | $-333.0K | · | |
| Stockholders' Equity | $19M | $38M | $65M | $103M | $147M | $-56M | |
| Liabilities + Equity | $23M | $45M | $74M | $118M | $153M | $21M | |
| Shares Outstanding | 1,261,685 | 1,258,940 | 25,030,188 | 30,764,160 | 30,609,029 | 1,875,422 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $122.0K | $551.0K | $571.0K | $614.0K | $685.0K | $209.0K | |
| Stock-based Comp | $1M | $3M | $4M | $6M | $6M | $1M | |
| Deferred Tax | $-3M | $-7M | $-10M | $-8M | $-8M | $-3M | |
| Restructuring | · | · | $200.0K | · | · | · | |
| Other Non-cash | $2M | $9M | $7M | · | $8M | · | |
| Operating Cash Flow | $-20M | $-25M | $-32M | $-39M | $-30M | $-18M | |
| CapEx | $16.0K | $146.0K | $180.0K | $321.0K | $2M | $1M | |
| Investing Cash Flow | $20M | $22M | $38M | $50M | $-143M | $-1M | |
| Stock Repurchased | · | · | $10M | · | · | · | |
| Net Stock Activity | · | · | $-10M | · | · | · | |
| Financing Cash Flow | $-645.0K | $-787.0K | $-11M | $-287.0K | $164M | $35M | |
| Net Change in Cash | $-1M | $-3M | $-5M | $11M | $-9M | $16M | |
| Free Cash Flow | $-20M | $-25M | $-32M | · | $-32M | · | |
| Levered FCF | $-21M | · | · | · | · | · |
Rentowność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -61.8% | -50.4% | -35.4% | · | -42.1% | · | |
| ROE | -91.9% | -71.7% | -50.2% | · | -24.4% | · | |
| ROIC | -119.9% | · | · | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 7.7 | 11.9 | · | 30.4 | · | |
| Quick Ratio | 2.0 | 1.8 | 2.3 | · | 30.2 | · | |
| Interest Coverage | -696.5 | -362.4 | -257.4 | · | -55.9 | · |
Wycena (TTM) 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-21M | $-30M | $-34M | $-49M | $-37M | $-20M | |
| Market Cap | $13M | $247M | $346M | · | $3.55B | · | |
| P/E | -0.6 | -0.4 | -11.3 | -18.9 | -87.2 | · | |
| P/B | 0.7 | 6.4 | 5.3 | · | 24.2 | · | |
| P / Tangible Book | 0.7 | 6.4 | 5.3 | 8.9 | 24.2 | · | |
| P / Cash Flow | -0.7 | -10.0 | -10.8 | · | -117.3 | · | |
| P / FCF | -0.7 | -9.9 | -10.8 | · | -110.0 | · | |
| Earnings Yield | -156.7% | -245.0% | -8.8% | -5.3% | -1.1% | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $3M | $2M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | $6M | $5M | $4M | $5M | |
| Operating Expenses | $5M | $5M | $5M | $7M | $8M | $8M | $8M | $9M | $8M | $8M | $10M | $11M | $13M | $14M | $11M | $12M | |
| Operating Income | $-5M | $-5M | $-5M | $-7M | $-8M | $-8M | $-8M | $-9M | $-8M | $-8M | $-10M | $-11M | $-13M | $-14M | $-11M | $-12M | |
| Interest Expense | $3.0K | $6.0K | $10.0K | $13.0K | $17.0K | $21.0K | $24.0K | $28.0K | $31.0K | $33.0K | $38.0K | $42.0K | $-206.0K | $10.0K | $172.0K | $243.0K | |
| Other Non-op | $-1.0K | $0 | $-1.0K | $-2.0K | $-1.0K | $0 | $0 | $-2.0K | $-67.0K | $-225.0K | $68.0K | $9.0K | $1.0K | $20.0K | $0 | $15.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income | $-5M | $-5M | $-5M | $-7M | $-8M | $-7M | $-7M | $-8M | $-7M | $-7M | $-9M | $-10M | $-12M | $-13M | $-11M | $-12M | |
| EPS (Basic) | $-8.92 | $-3.62 | $-3.91 | $-0.27 | $-12.23 | $-5.77 | $-5.69 | $-0.32 | $-0.30 | $-0.28 | $-0.31 | $-0.33 | $-0.40 | $-0.44 | $-0.34 | $-0.40 | |
| EPS (Diluted) | $-8.92 | $-3.62 | $-3.91 | $-0.27 | $-12.23 | $-5.77 | $-5.69 | $-0.32 | $-0.30 | $-0.28 | $-0.31 | $-0.33 | $-0.40 | $-0.44 | $-0.34 | $-0.40 | |
| Shares (Basic) | -26,453,748 | 1,261,290 | 1,260,867 | 25,192,363 | -26,305,779 | 1,257,299 | 1,255,145 | 25,049,111 | -58,934,363 | 25,514,115 | 30,507,018 | 30,866,087 | -61,366,433 | 30,720,291 | 30,701,758 | 30,647,679 | |
| Shares (Diluted) | -26,453,748 | 1,261,290 | 1,260,867 | 25,192,363 | -26,305,779 | 1,257,299 | 1,255,145 | 25,049,111 | -58,934,363 | 25,514,115 | 30,507,018 | 30,866,087 | -61,366,433 | 30,720,291 | 30,701,758 | 30,647,679 | |
| EBITDA | · | $-5M | $-5M | $-7M | · | $-8M | $-8M | $-9M | · | $-8M | $-10M | $-11M | · | $-14M | $-11M | $-12M |
Bilans 21
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $11M | $13M | $10M | $10M | $19M | $12M | $11M | $13M | $11M | $10M | $8M | $18M | $11M | $10M | $9M | |
| Prepaid Expense | $231.0K | $496.0K | $828.0K | $911.0K | $474.0K | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $1M | $2M | $3M | $3M | |
| Other Current Assets | $92.0K | $248.0K | $116.0K | $440.0K | $120.0K | $81.0K | $142.0K | $269.0K | $325.0K | $318.0K | $252.0K | $454.0K | $344.0K | $336.0K | $293.0K | $199.0K | |
| Current Assets | $22M | $26M | $30M | $36M | $42M | $48M | $54M | $60M | $67M | $74M | $81M | $99M | $109M | $118M | $127M | $139M | |
| PP&E (Net) | $82.0K | $112.0K | $143.0K | $159.0K | $417.0K | $899.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $622.0K | $622.0K | $623.0K | $607.0K | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | |
| Accum. Depreciation | $540.0K | $510.0K | $480.0K | $448.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | |
| Other Non-current Assets | $18.0K | $18.0K | $24.0K | $24.0K | $48.0K | $87.0K | $87.0K | $86.0K | $86.0K | $86.0K | $86.0K | $81.0K | $63.0K | $45.0K | $45.0K | $39.0K | |
| Total Assets | $23M | $28M | $32M | $38M | $45M | $53M | $60M | $67M | $74M | $82M | $90M | $108M | $118M | $129M | $138M | $150M | |
| Accounts Payable | $689.0K | $306.0K | $351.0K | $361.0K | $244.0K | $2M | $2M | $2M | $573.0K | $3M | $2M | $5M | $4M | $5M | $2M | $5M | |
| Accrued Liabilities | $715.0K | $1M | $704.0K | $2M | $847.0K | · | · | · | $900.0K | · | · | · | · | · | · | · | |
| Current Liabilities | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $8M | $9M | $8M | $5M | $8M | |
| Capital Leases | $59.0K | $146.0K | $592.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $67.0K | $68.0K | $67.0K | $67.0K | $72.0K | $34.0K | · | · | · | · | |
| Total Liabilities | $4M | $5M | $4M | $6M | $7M | $7M | $8M | $8M | $9M | $11M | $10M | $13M | $15M | $15M | $12M | $15M | |
| Common Stock | $0 | $0 | $0 | $3.0K | $0 | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-283M | $-278M | $-274M | $-269M | $-262M | $-254M | $-247M | $-240M | $-232M | $-224M | $-217M | $-208M | $-198M | $-186M | $-172M | $-162M | |
| AOCI | $1.0K | $-3.0K | $-11.0K | $-6.0K | $-13.0K | $14.0K | $-93.0K | $-137.0K | $-209.0K | $-402.0K | $-549.0K | $-823.0K | $-1M | $-1M | $-1M | $-899.0K | |
| Stockholders' Equity | $19M | $23M | $27M | $32M | $38M | $46M | $52M | $58M | $65M | $71M | $79M | $95M | $103M | $114M | $126M | $135M | |
| Liabilities + Equity | $23M | $28M | $32M | $38M | $45M | $53M | $60M | $67M | $74M | $82M | $90M | $108M | $118M | $129M | $138M | $150M | |
| Shares Outstanding | 1,261,685 | 1,261,290 | 1,261,290 | 25,208,068 | 1,258,940 | 25,151,379 | 25,124,333 | 25,073,958 | 25,030,188 | 24,996,517 | 26,583,819 | 30,971,341 | 30,764,160 | 30,720,921 | 30,720,921 | 30,682,813 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $30.0K | $30.0K | $32.0K | $30.0K | $139.0K | $140.0K | $135.0K | $137.0K | $135.0K | $137.0K | $138.0K | $161.0K | $162.0K | $151.0K | $144.0K | $157.0K | |
| Stock-based Comp | $295.0K | $254.0K | $264.0K | $461.0K | $391.0K | $733.0K | $795.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $-721.0K | · | · | · | $-977.0K | · | · | · | $-3M | · | · | · | $-17.0K | |
| Operating Cash Flow | $-4M | $-4M | $-6M | $-7M | $-6M | $-5M | $-6M | $-8M | $-6M | $-5M | $-9M | $-12M | $-10M | $-7M | $-12M | $-11M | |
| CapEx | $0 | $0 | $16.0K | $0 | $0 | $0 | $109.0K | $37.0K | $0 | $0 | $29.0K | $151.0K | $0 | $250.0K | $52.0K | $19.0K | |
| Investing Cash Flow | $2M | $2M | $9M | $7M | $-3M | $13M | $7M | $6M | $8M | $8M | $20M | $2M | $16M | $9M | $13M | $12M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $252.0K | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $-111.0K | $-152.0K | $-168.0K | $-214.0K | $-194.0K | $-204.0K | $-180.0K | $-209.0K | $-431.0K | $-3M | $-8M | $-262.0K | $-124.0K | · | · | $119.0K | |
| Net Change in Cash | $-2M | $-2M | $3M | $-117.0K | $-9M | $7M | $935.0K | $-2M | $2M | $1M | $2M | $-10M | $6M | $2M | $1M | $2M | |
| Free Cash Flow | · | · | · | $-7M | · | · | · | $-8M | · | · | · | $-12M | · | · | · | $-11M |
Rentowność 2
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -11.3% | -10.8% | -13.1% | · | -10.8% | -9.6% | -9.2% | · | -6.8% | -8.2% | -7.9% | · | -9.2% | -6.9% | -7.6% | |
| ROE | · | -13.3% | -12.4% | -15.2% | · | -12.4% | -10.9% | -10.4% | · | -7.7% | -9.2% | -8.8% | · | -10.0% | -7.3% | -8.1% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.8 | 7.6 | 6.8 | · | 8.8 | 10.9 | 12.1 | · | 11.9 | 15.1 | 13.0 | · | 14.0 | 23.5 | 18.3 | |
| Quick Ratio | · | 2.4 | 3.2 | 1.9 | · | 3.5 | 2.4 | 2.2 | · | 1.8 | 1.9 | 1.1 | · | 1.3 | 1.8 | 1.1 | |
| Interest Coverage | · | -808.5 | -520.6 | -559.5 | · | -372.5 | -324.5 | -311.8 | · | -234.5 | -267.8 | -262.1 | · | -1394.1 | -62.3 | -51.4 |
Wycena (TTM) 8
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-24M | $-26M | $-29M | · | $-30M | $-32M | $-35M | · | $-40M | $-44M | $-47M | · | $-46M | $-42M | $-40M | |
| Market Cap | · | $12M | $11M | $199M | · | $301M | $312M | $527M | · | $400M | $606M | $929M | · | $952M | $1.39B | $1.42B | |
| P/E | · | -0.7 | -0.5 | -0.7 | · | -1.0 | -1.9 | -16.9 | · | -11.8 | -16.1 | -19.9 | · | -20.7 | · | · | |
| P/B | · | 0.5 | 0.4 | 6.2 | · | 6.6 | 6.0 | 9.0 | · | 5.6 | 7.7 | 9.8 | · | 8.4 | 11.1 | 10.5 | |
| P / Tangible Book | · | 0.5 | 0.4 | 6.2 | · | 6.6 | 6.0 | 9.0 | · | 5.6 | 7.7 | 9.8 | · | 8.4 | 11.1 | 10.5 | |
| P / Cash Flow | · | · | · | -28.0 | · | · | · | -69.1 | · | · | · | -79.2 | · | · | · | -131.9 | |
| P / FCF | · | · | · | -28.0 | · | · | · | -68.8 | · | · | · | -78.2 | · | · | · | -131.6 | |
| Earnings Yield | · | -143.6% | -182.3% | -152.9% | · | -100.8% | -53.2% | -5.9% | · | -8.5% | -6.2% | -5.0% | · | -4.8% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-21M | $-30M | $-34M | $-49M | $-37M |
| Rozwodniony EPS | $-16.72 | $-24.01 | $-1.22 | $-1.58 | $-1.33 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.1 | 7.7 | 11.9 | — | 30.4 |
| Wskaźnik Szybkości | 2.0 | 1.8 | 2.3 | — | 30.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-20M | $-25M | $-32M | — | $-32M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.